Nuvectis Pharma, Inc. Common Stock (NVCT) is a publicly traded Healthcare sector company. As of July 7, 2026, NVCT trades at $19.20 with a market cap of $618.85M and a P/E ratio of -14.54. NVCT moved -2.24% today. Year to date, NVCT is +160.16%; over the trailing twelve months it is +144.59%. Its 52-week range spans $4.44 to $29.28. Analyst consensus is strong buy with an average price target of $27.75. Rallies surfaces NVCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NVCT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $19.20 |
| Market Cap | $618.85M |
| P/E Ratio | -14.54 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.28 |
| 52-Week Low | $4.44 |
| Volume | 408.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.44M |
| Gross Margin | 0.00% |
4 analysts cover NVCT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.75.